Pore formation by pore forming membrane proteins towards infections
A Sannigrahi, K Chattopadhyay - Advances in Protein Chemistry and …, 2022 - Elsevier
Over the last 25 years, the biology of membrane proteins, including the PFPs-membranes
interactions is seeking attention for the development of successful drug molecules against a …
interactions is seeking attention for the development of successful drug molecules against a …
[PDF][PDF] Recombinant proteins: Their potential roles in the diagnosis of bovine tuberculosis: A review
D Behera, A Samal, AK Sahoo, H Verma, N Debbarma - 2024 - researchgate.net
Tuberculosis (TB) is a highly contagious, economically devastating and wasting disease of
both man and animal and is primarily caused by Mycobacterium tuberculosis and …
both man and animal and is primarily caused by Mycobacterium tuberculosis and …
[HTML][HTML] Design and construction of a cloning vector containing the hspX gene of mycobacterium tuberculosis
Background: Tuberculosis (TB) is a major cause of death worldwide. Finding an effective
vaccine against TB is the best way to control it. Several vaccines against this disease have …
vaccine against TB is the best way to control it. Several vaccines against this disease have …
[HTML][HTML] Production of MPT-64 recombinant protein from virulent strain of Mycobacterium bovis
MM Tashakkori, M Tabatabaei… - Iranian Journal of …, 2018 - ncbi.nlm.nih.gov
Tuberculosis (TB) is a zoonotic infectious disease common to humans and animals which
has been caused by a rod shaped, acid fast bacterium, called Mycobacterium bovis. The …
has been caused by a rod shaped, acid fast bacterium, called Mycobacterium bovis. The …
Discovering and exploiting bacterial proteins as anticancer agents
GEFM da Silva - 2013 - search.proquest.com
Azurin is a low molecular weight protein, produced by Pseudomonas aeruginosaand
possesses several antitumor properties, like causing P-cadherin levels to decrease in …
possesses several antitumor properties, like causing P-cadherin levels to decrease in …
Рекомбінантні антитіла для фундаментальних і прикладних досліджень (за матеріалами наукового повідомлення на засіданні Президії НАН України 7 травня …
ОС Олійник - Вісник НАН України, 2014 - dspace.nbuv.gov.ua
Технологія рекомбінантних антитіл є потужним підходом для отримання нових
діагностичних та терапевтичних реагентів. Рекомбінантні антитіла можна …
діагностичних та терапевтичних реагентів. Рекомбінантні антитіла можна …